Article

lock Open Access lock Peer-Reviewed

19

Views

ORIGINAL ARTICLE

Pulsatile stent graft: a new alternative in chronic ventricular assistance

José Honório PalmaI; Diego Felipe GaiaII; Guido CAPUTIIII; Guilherme AgreliIV; João Roberto BredaV; Domingo M. BraileVI; Enio BuffoloVII

DOI: 10.5935/1678-9741.20130031

ABBREVIATIONS AND ACRONYMS

ATP Adenosine triphosphate

NITINOL (Nickel Titanium Naval Ordinance Laboratory)

PVC Polyvinyl chloride

SMA (shape memory alloy)

INTRODUCTION

Heart failure is currently one of the most common causes of cardiac hospital stay, and also causes significant morbidity and mortality [1].

Several chronic circulatory assist devices have been tested in recent years, and in most cases are often highly complex, and devices difficult to control which implantation depends on major procedures. The devices are also designed to be definitive or temporary, serving as a bridge to heart transplantation [2-4].

In recent years, the alloy NITINOL (Nickel Titanium Naval Ordinance Laboratory) initially used for various applications in the naval branch recognized for being "smart material" or SMA (shape memory alloy), has been used in medicine, in several areas, as orthopedic, cardiac, urological and gastrointestinal prostheses and orthodontic devices. This alloy behaves like a biological system that converts electrical or thermal energy in contraction and movement simulating a "natural muscle" [5-9].

Nitinol has the characteristic of retrieving a defined geometric shape after change in temperature. This ability is due to the modification of the alloy crystalline structure after stimulation. This material exhibits two-phase crystal structure: martensite, which has almost elastic properties, allowing deformation of the material without structural damage, and austenite phase, which has a more rigid and defined structure [10,11].

The aim of this study was to decribe an endoprosthesis contractile made with nitinol frame, still in "in-vitro" laboratory testing, whose function is to apply a chronic pulse inside the descending aorta, similar to that produced by an intra-aortic balloon, being synchronized with the cardiac cycle for outpatient non-invasive chronic circulatory support.

 

METHODS

The principle of the device is to change the structure of the stent between two states: relaxed (martensitic structure) and activated (austenitic structure), where the change of the diameter of the stent results in changing the volume of the sample, causing ejection of the resulting difference between the two conditions (Figure 1).

 

 

The endoprosthesis pulsatile tested was constructed with a metal strut of nickel and titanium designed as independent Gianturco Z-endoprostheses with 13.5 mm in height and 10 vertices. The metal structure involved a natural rubber latex tubular membrane, flexible and waterproof, 0.4 mm thick and 28 mm in diameter. The wire comprising nickel and titanium alloy had the following thermoelectric characteristics:

Resistivity: ρe=76µΩ.cm

Density ρm=6,5g/cm3

Boiling point: Tfusão=1310ºC

Temperature of total transformation to the austenitic phase: Af=60ºC

Coefficient of linear expansion: dl/dT=6,6.10-6/ºC

Changing the stent was caused by the application of electrical current in metallic structures, which promoted heating and induced the shape change. When stimulated by temperature or by electricity, the league turns from its martensitic form (relaxed) and returns to its austenitic phase (activated), with its defined geometric shape and can be deformed again without structural damage.

Initially, the stent structure is shaped with a diameter of 10 mm and then, upon cooling up to room temperature, expanded to 28 mm in diameter. The cycle shown in Figure 2 illustrates the deformation experienced by the stent. In the first cycle, the structure undergoes forced expansion at low temperatures, from 10 mm to 28 mm in diameter, at room temperature. In the cycle II, with the application of current, the structure temperature rises and the return to the initial diameter in which the stent was molded occurrs. The cycle is then divided in steps relaxation (I) and activation (II). The pulsatile endoprosthesis was connected to a polyvinyl chloride (PVC) tube of 12.5 mm in internal diameter and 500 mm in length. The system was mounted vertically and filled with saline solution with blue dye at room temperature into a column of 400 mm (400 mm H2O pressure equivalent to 30 mmHg) (Figure 3).

 

 

 

 

Cages produced with nickel and titanium wire were connected in series and connected to a pulse controller and an oscilloscope to view the profile of the electric current. This system was connected to a voltage source which supplied up to 7 amps of current, with voltage up to 220 Volts Figure 4.

 

 

The PVC tube was graduated in order to measure the movement of water caused by the contraction of the pulsatile stent. With the variation in the water column we can calculate the displaced volume during contraction.

Temperature and relative humidity were, respectively, 21.2ºC and 58.3%. There were performed two test sequences: the first sequence with a montage of 2 cages covering the latex membrane and the second sequence with 5 cages. In the first series, with only two cages (length 30 mm) we applied a voltage of 16.3 volts and a current of 5 amperes, with pulses of 1 second at intervals of 0.23 second. Stents were connected in series with the control and power supply system.

In a second test sequence, we used five stents connected in series, coating 80mm of the latex tubular membrane. For this system, we used a voltage of 15 volts, 7 amps current, pulse interval of 2.88 seconds, 7.12 seconds between pulses.

 

RESULTS

In the first test sequence was obtained pulsatile effect of two stents, with contraction of the tube and displacement of the water column sufficient to validate the endoprosthesis pulsating effect. The time intervals set in the pulse controller allowed the contraction of the frames, as well as their relaxation in the intervals between pulses. In this condition, the two structures ejected volume of 2.6 ml per cycle, with a range of 29 mm for the height of the water column and the variation in diameter of 2.2 mm (initial diameter 28 mm, end diameter of 25.8 mm in the 30 mm in length of the prosthesis), equivalent to 8% of contraction during pulsation (Figure 5).

 

 

In the second test sequence (5 stents) we obtained range of 61 mm in the column and a 7.4 mL volume per cycle (initial diameter 28 mm, 25.8 mm end diameter in 80 mm of the prosthesis) equivalent to 8% contraction during pulsation (Figure 6).

 

 

DISCUSSION

The contractile stent is an initial prototype for cardiac assist, based on "smarts materials" technology, for the treatment of chronic heart failure. The circulatory assist devices for the treatment of chronic heart failure currently available present great complexity of handling, both at the time of implantation and in outpatient. Unlike the engines used in these devices, the called artificial muscles are light and consume little power. The use of nickel-titanium alloy for making assist devices such as artificial muscle opens new horizons in this field.

Various materials have been tested and are used in various areas of medicine, and one important class of these are the shape memory polymers that have, or that is, those that return to their shape when stimulated, in adittion to be also biocompatible. This property allows them to be released in a compact form and minimally invasive manner. These polymers are used in orthopedic prostheses and embolization coil for treatment of cerebral aneurysms [12-15].

Each one of some other materials that could be used for these devices present a restriction. The gel polymer, abandoned by high energy expenditure, as well as cobalt-based alloys or stainless steel, present major limitation which is the small deformity, limited to around 1%.

One of the main reasons for the choice of alloy nitinol for construction of artificial muscles is due to the fact that the energy used seems to be more efficient. In addition, the nitinol alloy presents superelastic or pseudoelastic property, which allows a deformity of more than 10% [11].

The advantages and qualities of the use of nickel-titanium in medicine are known since 1970, when the first ventricular assist devices were manufactured. At that time, however, major problems could not be solved, such as material fatigue, heating and energy source for their stimulation, but the league continued to be widely used as self-expandable stents in the treatment of aneurysms and dissections.

Today, one of the first studies using this technology in cardiology is a prosthesis developed with the aim of helping the atrial contraction. In this study, attention is drawn to the fact that there is no need to use an engine because the league contracts alone. In the field of atrial fibrillation, the device already is a reality, proving that actually generates atrial output for ventricular fibrillation, and can even be used to support two biatrial assistant devices. The auxiliary device improves the right atrial ejection fraction in 7% during rapid stimulation, simulating an atrial contraction [16].

The device tested, according the parameters observed in the laboratory, allows researches to continue, because the ejected volume obtained was 7.4 mL per cycle, which leads us to predict a volume of 595.2 mL when adjusted to a frequency of 80 beats per minute. This corresponds to 10% of the approximate cardiac output of a normal adults. These measurements were made with the use of a stent of 80 mm in length and 28 mm in diameter with a contraction of only 8%.

Example:

7.44mL x 80bpm = 595.2 mL/min

Cardiac output = 70 mL per beat x 80 bpm = 5600 mL/min

Assistance: 595.2 mL/5600mL = 10.6% aid

The amplitude of the material contraction depends on the choice of the ratio between nickel and titanium in the alloy, the thickness of the wire used, the geometry of the stent and the endoprosthesis length to be implanted. All these characteristics influence the efficiency of the device and the energy required for the operation depends on these factors.

The biological motor system was so successful during evolution that has been adopted by all types of striated muscle (skeletal muscle and heart). In the sarcomere, the muscle fibers contract from the sliding of actin and myosin, unlike the contraction generated by the proposed alloy, where shortening occurs by changing the molecular structure of the material. The maximum mechanical performance of all natural muscle varies between 40 and 200 watts per kilogram of muscle, and the performance efficiency in relation to the consumption of adenosine triphosphate (ATP) is about 50%. In these tests, we obtained efficiency in converting electrical energy into fluid ejection quite low, approximately 1%. The low efficiency is due to the alloy used, which should have its temperature raised to 80ºC to have a shape memory enabled. With the use of an alloy with processing at temperatures of about 43ºC, the required amount of power falls drastically reducing energy consumption and enhancing efficiency, which will be performed in future tests.

The allow stimulation necessary to present contraction is another important point of discussion, because the energy required should ideally be provided by a generator similar to our known pacemaker or defibrillator. In the studies performed for making atrial contraction prosthesis, we used intermittent electrical current of 10 volts, 300 mA and 100 ms. Ont the other hand, in esophageal contractile prosthesis [11], the stimulus was 500 mA at 5 volts. In this study, we used the largest currents and voltages (16V and 5A) due to the characteristic of the alloy tested and its activation at 80ºC.

Another point to be questioned when we think of using these devices is the durability of the material being subjected to fatigue (contraction) in the long-term. In the state-of-the-art aortic stents made of nickel-titanium, there is no fracture of the material even when observed that there is a pulsatile movement of the stent following the movement of the aortic wall. The post-implant contractile property can also be changed in view of the same prosthesis interaction with the aortic wall and its consequent inflammatory reaction and long-term change of the alloy crystalline structure, with loss of ability to move. Future tests will probably include a coating.

For the contractile function of the stent is similar to an intraaortic balloon of 40cc, it is necessary to optimize the design with the use of a composition of a shape memory alloy which is more efficient from the standpoint of energy for working physiological temperature, which offers greater structural rigidity in its activated form to achieve greater contraction. As an example, a stent of 28 mm in diameter when relaxed and with 130 mm in length has to contract to 17 mm, representing a 40% compliance. It is still possible to synchronize the functioning of individual pulsatile stents comprising the prosthesis to allow it to be unidirectional or bidirectional, directing blood flow to the coronary and carotid arteries or dividing them between visceral and supra-aortic and coronary arteries.

 

CONCLUSION

The results obtained confirm the pulsatile stent contractility activated by the application of electric current. The continued study and refinement of the material are needed to obtain a more efficient model from the point of view of energy and greater pulse, in order to allow ejection volumes comparable to intra-aortic balloons used in routine care for circulatory support.

If the expectation is confirmed, we have a non-invasive outpatient circulatory assist, with indications and effectiveness of intra-aortic balloon.

REFERENCES

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220. [MedLine]

2. Jokinen JJ, Mildh L, Hämmäinen P, Taal G, Raivio P, Suojaranta-Ylinen R, et al. Mechanical support for the heart and circulation in adults. Duodecim. 2011;127(19):2045-53. [MedLine]

3. Louis LB 4th, Sun B. Advances in mechanical circulatory support. Curr Opin Organ Transplant. 2008;13(5):522-5. [MedLine]

4. Delgado RM 3rd, Bergheim M. Management of acute and chronic heart failure with left ventricular assist devices. Am Heart Hosp J. 2005;3(3):153-60. [MedLine]

5. Babighian G, Fontana M, Caltran S, Ciccolella M, Amadori M, De Zen M. The heat-activated stapes prosthesis 'SMart' Piston: technique and preliminary results. Adv Otorhinolaryngol. 2007;65:190-6. [MedLine]

6. Carosio S, Monero A. Smart and hybrid materials: perspectives for their use in textile structures for better health care. Stud Health Technol Inform. 2004;108:335-43. [MedLine]

7. Roosli C, Schmid P, Huber AM. Biocompatibility of nitinol stapes prosthesis. Otol Neurotol. 2011;32(2):265-70. [MedLine]

8. Schaub MC. Artificial muscle: facts and fiction. Swiss Med Wkly. 2011;141:w13319. [MedLine]

9. Tarnita D, Tarnita DN, Hacman L, Copilus C, Berceanu C. In vitro experiment of the modular orthopedic plate based on Nitinol, used for human radius bone fractures. Rom J Morphol Embryol. 2010;51(2):315-20. [MedLine]

10. Dotter CT, Buschmann RW, McKinney MK, Rösch J. Transluminal expandable nitinol coil stent grafting: preliminary report. Radiology. 1983;147(1):259-60. [MedLine]

11. Stoeckel D, Pelton A, Duerig T. Self-expanding nitinol stents: material and design considerations. Eur Radiol. 2004;14(2):292-301. [MedLine]

12. Sokolowski W, Metcalfe A, Hayashi S, Yahia L, Raymond J. Medical applications of shape memory polymers. Biomed Mater. 2007;2(1):S23-7. [MedLine]

13. Lendlein A, Rehahn M, Buchmeiser MR, Haag R. Polymers in biomedicine and electronics. Macromol Rapid Commun. 2010;31(17):1487-91. [MedLine]

14. Lendlein A, Shastri VP. Stimuli-sensitive polymers. Adv Mater. 2010;22(31):3344-7. [MedLine]

15. Lendlein A, Pierce BF, Ambrosio L, Grijpma DW. Advanced functional polymers for medicine. Macromol Biosci. 2011;11(12):1621-4. [MedLine]

16. Tozzi P, Hayoz D, Thévenaz P, Roulet JY, Salchli F, von Segesser LK. Atria assist device to restore transport function of fibrillating atrium. Eur J Cardiothorac Surg. 2008;33(2):263-7. [MedLine]

Article receive on Thursday, December 6, 2012

CCBY All scientific articles published at bjcvs.org are licensed under a Creative Commons license

Indexes

All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery DEVELOPMENT BY